Aluminium-mediated neurodegeneration has been well established as an experimental model of AD [21, 22], associated with elevated β-amyloid deposition [23], diminished cholinergic transmission, overexpression of phosphorylated Tau [24], and neuronal death [25]. Here, MAPT is linked to Alzheimer disease.